Cargando…
Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report
Neurofibromatosis type 1 (NF1) is a common genetic disorder. Pain is a major symptom of this disease which can be secondary to the development of plexiform and subcutaneous neurofibromas, musculoskeletal symptoms (such as scoliosis and pseudoarthrosis), and headaches. Visible neurofibromas add signi...
Autores principales: | Hegazy, Omar, Platnick, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944157/ https://www.ncbi.nlm.nih.gov/pubmed/31938604 http://dx.doi.org/10.7759/cureus.6312 |
Ejemplares similares
-
Bevacizumab for Treatment-Refractory Pain Control in Neurofibromatosis Patients
por: Linda, Xu W, et al.
Publicado: (2016) -
The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
por: Bakewell, Brock K, et al.
Publicado: (2022) -
Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study
por: Ma, Lucy, et al.
Publicado: (2022) -
Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease
por: Gusho, Charles A, et al.
Publicado: (2020) -
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022)